Kathryn Elaine Stephenson

Title: Kathryn Elaine Stephenson: Innovator in Monoclonal Antibodies

Introduction

Kathryn Elaine Stephenson is a notable inventor based in Boston, MA, recognized for her contributions to the field of medical science. She has developed innovative solutions aimed at combating viral infections, particularly focusing on the Zika virus.

Latest Patents

Kathryn holds a patent for "Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination." This invention provides antibodies that are effective against the Zika virus. The novel polypeptides she developed can be utilized alone or as components of larger molecules, such as antibodies or antibody fragments, to treat or prevent Zika virus infections.

Career Highlights

Throughout her career, Kathryn has worked with esteemed organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Beth Israel Deaconess Medical Center. Her work has significantly contributed to advancements in medical research and treatment methodologies.

Collaborations

Kathryn has collaborated with professionals such as Shelly Krebs and Gina Donofrio, enhancing her research and development efforts in the field of viral infections.

Conclusion

Kathryn Elaine Stephenson's innovative work in developing monoclonal antibodies represents a significant advancement in the fight against viral diseases. Her contributions continue to impact the medical community positively.